Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement

JAMA - Journal of the American Medical Association

Volumn 316, Issue 6, 2016, Pages 625-633

  Bibbins Domingo, Kirsten ^a   Grossman, David C ^b   Curry, Susan J ^c   Davidson, Karina W ^d   Epling, John W ^e   García, Francisco A R ^f   Gillman, Matthew W ^g   Kemper, Alex R ^h   Krist, Alex H ^i,j   Kurth, Ann E ^k   Seth Landefeld, C ^l   LeFevre, Michael ^m   Mangione, Carol M ⁿ   Phillips, William R ^o   Phipps, Maureen G ^p   Pignone, Michael P ^q   Siu, Albert L ^r,s  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f Pima County Department of Health   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h DUKE UNIVERSITY   (United States)

ⁱ Fairfax Family Practice Residency ^*  (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^k YALE UNIVERSITY   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m UNIVERSITY OF MISSOURI   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF WASHINGTON   (United States)

^p BROWN UNIVERSITY   (United States)

^q UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^r MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^s VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL DECISION MAKING; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FEASIBILITY STUDY; GENE MUTATION; GENETIC VARIABILITY; HEART INFARCTION; HETEROZYGOTE; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; MASS SCREENING; MULTIFACTORIAL DYSLIPIDEMIA; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ADVERSE EFFECTS; ADVISORY COMMITTEE; ASYMPTOMATIC DISEASE; BLOOD; CARDIOVASCULAR DISEASES; CHILD; DYSLIPIDEMIAS; GENETICS; HYPERLIPOPROTEINEMIA TYPE II; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PROCEDURES; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADVISORY COMMITTEES; ASYMPTOMATIC DISEASES; CARDIOVASCULAR DISEASES; CHILD; DYSLIPIDEMIAS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPIDS; MASS SCREENING; PREVENTIVE HEALTH SERVICES; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 84981229108     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.9852     Document Type: Article

References (33)

1. Lozano P, Henrikson NB, Dunn J, et al. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 141. Rockville, MD: Agency for Healthcare Research and Quality; 2016. AHRQ Publication No. 14-05204-EF-2.
2. Lozano P, Henrikson NB, Dunn J, et al. Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 140. Rockville, MD: Agency for Healthcare Research and Quality; 2016. AHRQ Publication No. 14-05204-EF-1.
3. Lozano P, Henrikson NB, Dunn J, et al. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. doi:10.1001/jama.2016.6176.
4. Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr. 2015;169(3):272-279.
5. Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA. 2012;308(6):591-600.
6. Lozano P, Henrikson NB, Morrison C, et al. Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. doi:10.1001/jama.2016.6423.
7. Slack J. Risks of ischaemic heart disease in familial hyperlipoproteinaemic states. Lancet. 1969;2(7635):1380-1382.
8. Stone NJ, Levy RI, Fredrickson DS, Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974;49(3):476-488.
9. Setia N, Verma IC, Khan B, et al. Premature coronary artery disease and familial hypercholesterolemia: need for early diagnosis and cascade screening in the Indian population [published onlineOctober 27, 2011]. Cardiol Res Pract. doi:10.1155/2012/658526.
10. Vinci SR, Rifas-Shiman SL, Cheng JK, Mannix RC, Gillman MW, de Ferranti SD. Cholesterol testing among children and adolescents during health visits. JAMA. 2014;311(17):1804-1807.
11. Joyce N, Wellenius GA, Dore DD, Newburger JW, Zachariah JP. Patterns of lipid lowering therapy among children ages 8-20 years. J Pediatr. 2015;167(1):113-119.
12. Tamir I, Heiss G, Glueck CJ, Christensen B, Kwiterovich P, Rifkind BM. Lipid and lipoprotein distributions in white children ages 6-19 yr: the Lipid Research Clinics Program Prevalence Study. J Chronic Dis. 1981;34(1):27-39.
13. Cook S, Auinger P, Huang TT. Growth curves for cardio-metabolic risk factors in children and adolescents. J Pediatr. 2009;155(3):6.e15-6.e26.
14. National Cholesterol Education Program (NCEP). National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3):495-501.
15. Haney EM, Huffman LH, Bougatsos C, Freeman M, Steiner RD, Nelson HD. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2007;120(1):e189-e214.
16. Clarke WR, Schrott HG, Leaverton PE, Connor WE, Lauer RM. Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation. 1978;58(4):626-634.
17. Magnussen CG, Raitakari OT, Thomson R, et al. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circulation. 2008;117(1):32-42.
18. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256.
19. Eiland LS, Luttrell PK. Use of statins for dyslipidemia in the pediatric population. J Pediatr Pharmacol Ther. 2010;15(3):160-172.
20. Barton M; US Preventive Services Task Force. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. Pediatrics. 2010;125(2):361-367.
21. Moyer VA; U. S. Preventive Services Task Force. Screening for primary hypertension in children and adolescents: U. S. Preventive Services Task Force recommendation statement. Pediatrics. 2013;132(5):907-914.
22. Vuorio A, Docherty KF, Humphries SE, Kuoppala J, Kovanen PT. Statin treatment of children with familial hypercholesterolemia-trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus? Atherosclerosis. 2013;226(2):315-320.
23. US Preventive Services Task Force. Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement. Pediatrics. 2007;120(1):e215-e219.
24. Cottrell L, John C, Murphy E, et al. Individual-, family-, community-, and policy-level impact of a school-based cardiovascular risk detection screening program for children in underserved, rural areas: the CARDIAC Project [published online June 5, 2013]. J Obes. doi:10.1155/2013/732579.
25. Skovby F, Micic S, Jepsen B, et al. Screening for familial hypercholesterolaemia by measurement of apolipoproteins in capillary blood. Arch Dis Child. 1991;66(7):844-847.
26. Garcia RE, Moodie DS. Routine cholesterol surveillance in childhood. Pediatrics. 1989;84(5):751-755.
27. Obarzanek E, Hunsberger SA, Van Horn L, et al. Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics. 1997;100(1):51-59.
28. Wong H, Chahal N, Manlhiot C, Niedra E, McCrindle BW. Flaxseed in pediatric hyperlipidemia: a placebo-controlled, blinded, randomized clinical trial of dietary flaxseed supplementation for children and adolescents with hypercholesterolemia. JAMA Pediatr. 2013;167(8):708-713.
29. Saydah S, Bullard KM, Imperatore G, Geiss L, Gregg EW. Cardiometabolic risk factors among US adolescents and young adults and risk of early mortality. Pediatrics. 2013;131(3):e679-e686.
30. Kusters DM, Avis HJ, de Groot E, et al. Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia. JAMA. 2014;312(10):1055-1057.
31. American Academy of Pediatrics (AAP). Recommendations for Preventive Pediatric Health Care. https://www.aap.org/en-us/professional-resources/practice-support/Periodicity/Periodicity %20Schedule-FINAL.pdf. 2015. Accessed December 15, 2015.
32. American Academy of Family Physicians (AAFP). Clinical Preventive Service Recommendation: Lipid Disorders, Infants, Children, Adolescents, and Young Adults. http://www.aafp.org/patient-care/clinical-recommendations/all/lipid-disorders.html. 2007. Accessed December 15, 2015.
33. UK National Screening Committee (UK NSC). The UK NSC Recommendation on Familial Hypercholesterolaemia Screening in Children. http://legacy.screening.nhs.uk/familialhypercholesterolaemia-child. 2015. Accessed December 15, 2015.